Crouzon disease: genes and variants

Explore variant evidence for Crouzon disease across 1 analyzed protein (FGFR2). Linked ClinVar records include 22 pathogenic or likely pathogenic variants, 35 variants of uncertain significance and 10 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-10-10. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Crouzon disease

Where Crouzon disease variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Crouzon disease

VariantPositionProtein partClinical label
FGFR2 W290R290Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 W290G290Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 Y105C105Ig-like C2-type 1Pathogenic / likely pathogenic (★★)
FGFR2 C278F278Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 D336G336Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 A337P337Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 G338R338Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 C342S342Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 C342Y342Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 S252W252ExtracellularPathogenic / likely pathogenic (★★)
FGFR2 G271V271Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 F276V276Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 Y281C281Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 Y308C308Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 L357S357Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 G384R384TransmembranePathogenic / likely pathogenic (★★)
FGFR2 A109P109Ig-like C2-type 1Pathogenic / likely pathogenic (★★)
FGFR2 G272R272Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 N549H549Protein kinasePathogenic / likely pathogenic (★★)
FGFR2 G182V182Ig-like C2-type 2Pathogenic / likely pathogenic (★★)
FGFR2 Y328C328Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
FGFR2 W290S290Ig-like C2-type 3Pathogenic / likely pathogenic (★)

Which prediction tools work for Crouzon disease

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Crouzon disease

Frequently asked questions

Which genes have records linked to Crouzon disease?

This view contains 1 analyzed proteins: FGFR2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 22 pathogenic or likely pathogenic variants, 35 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 89 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center